Unlike many other diseases, cancer care is uniquely complex, involving prolonged treatment regimens, high costs, and significant emotional distress for patients and their families.
Filter insights by:
Showing 6 of 22 content results
Get insights on Q3 2024 pharma and healthcare deals covers record-high domestic deals, PE trends, and capital market activity reshaping India's healthcare industry.
Discover Grant Thornton Bharat's insights into the inclusive budget's role in fostering a healthier and vibrant India. Learn about key policies on society.
As India anticipates its new budget announcement, there is a heightened sense of expectation, especially within the Government & Public Services (G&PS) sector.
Q2 2024 sees a advancement in Indian healthcare & pharma deals. Seen increased investments in API, biotechnology, and CDMO segments. Explore insights now.
Our latest report, “Impact of climate change on human health: Decoding the risks,” highlights the urgent need for intersectoral collaboration across environment, health, energy, transport, and food sectors.